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A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by 
promoting apoptosis.  
 














Supplementary Fig. 1. UNC5B exon 8 inclusion in VastDB and its NOVA2-mediated regulation in ECs. a UNC5B 
exon 8 PSI (Percent Spliced-In) correlation with several SRFs − including SRSF1 (red), NOVA2 (blue), HNRNPA1 
(green), SRSF3 (orange), HNRNPC (cyan), or RBFOX2 (magenta) − cRPKM expression values annotated in the 
Vertebrate Alternative Splicing and Transcription Database (VastDB; http://vastdb.crg.eu/). Pearson r values, associated 
P-values, and linear regression (black line) are shown. b Left: analysis by RT-qPCR (relative to Ubb) and 
immunoblotting of NOVA2 HA-tagged expression levels in NOVA2 overexpressing moEC; GAPDH as loading 
control. Right: analysis by RT-PCR of Unc5b exon 8 splicing profile in the above ECs. n=3. c Left: analysis by RT-
qPCR (relative to Ubb) and immunoblotting of NOVA2 expression levels in NOVA2-depleted lu2EC; VINCULIN as 
loading control. Right: analysis by RT-PCR of Unc5b exon 8 AS profile in the above ECs. n=3. d NOVA2 mRNA 
levels (relative to ACTB) and AS analysis of UNC5B exon 8 in human primary ECs (HUVEC) stably expressing a pool 
of shRNAs against NOVA2 or with a control shRNA pool. n=3. e COL4A1 mRNA expression levels (relative to B2M) 
during in vitro angiogenesis of HUVEC/TERT2 plated on Matrigel-coated culture plates. h = hours after seeding. n=3. 
The percentage of exon inclusion is shown below each gel. Two-tailed Student’s t-test or one-way ANOVA for multiple 




Supplementary Fig. 2. UNC5B exon 8 splicing and NOVA2 expression levels are regulated by cell density in ECs. 
Left: NOVA2 expression levels in moEC (a; n=3), lu2EC (b; n=6), and HUVEC/TERT2 (c; n=3) grown at different 
densities (sparse: Spa.; confluent: Conf.) were analyzed by RT-qPCR (relative to mouse Ubb or human ACTB) and 
immunoblotting. VINCULIN or α-TUBULIN as loading controls. Right: RT-PCR analysis of UNC5B exon 8 AS 
profiles in the above ECs grown as sparse (Spa.) or confluent (Conf.). The percentage of exon inclusion is shown below 
each gel. Two-tailed Student’s t-test; Error bars indicate ±SEM. Exact P-values (P) are indicated: * < 0.05; ** < 0.01; 





Supplementary Fig. 3. Prediction of NOVA2 binding motifs in Unc5b pre-mRNA. a Scheme of the Unc5b mouse 
genomic region analyzed with the RBPmap program. NOVA2 binding motifs are indicated as vertical orange bars. 
Right: top 15 predicted RNA binding motifs and their relative position to the Unc5b exon7-intron7 junction. b 
Prediction of RNA binding motifs in Unc5b mouse genomic region by using SpliceAid 2. c Scheme of the UNC5B 
human genomic region analyzed with the RBPmap program. NOVA2 binding motifs are indicated as vertical orange 
bars. Right: top 15 predicted RNA binding motifs and their relative position to the UNC5B exon7-intron7 junction. For 
RBPmap and SpliceAid 2 analyses, recognized motifs, and relative position to the Unc5b exon7-intron7 junction are 








Supplementary Fig. 4. NOVA2 specifically recognizes the YCAY cluster in Unc5b intron 7. a Left: schematic 
representation of mouse Unc5b pre-mRNA encompassing exon 7 and 9. NOVA2 binding sites (YCAY sites) identified 
by RBPmap are shown as vertical bars. Bars of various colors indicate the different Z-scores calculated by RBPmap 
(orange: Z-score ≥ 3.50; pale orange: Z-score < 3.50 & ≥ 2.75; yellow: Z-score < 2.75 & ≥ 2.00). 100-nt length 
riboprobes for the in vitro pull-down assay are indicated below; in the mutated riboprobe, YCAY repeats were replaced 
with YAAY. Wt and Mut riboprobes contain at the 3' end TDP-43 binding motifs (CACACACACACACACAC; green 
segments). Right: in vitro RNA pull-down assay with NOVA2-HA over-expressing HeLa cellular extracts and the 
indicated riboprobes. Streptavidin resin only pull-down was loaded as an additional control (beads). TDP-43 
immunoblotting as an internal control. b Left: silencing of RBFOX2 in moEC was verified by immunoblotting. 
VINCULIN as loading control. Center: RT-PCR analysis of Unc5b exon 8 splicing in the same ECs. Right: schematic 
representation of the RBFOX binding sites identified by using RBPmap. For RBPmap analysis, recognized motifs, 
statistical parameters (Z-score and P-value), and relative position to the Unc5b exon 7-intron 7 junction are also shown. 
The percentage of exon inclusion is shown below each gel. At least three independent biological replicates were 













Supplementary Fig. 5. Unc5b-Δ8 specifically promotes PAV formation in zebrafish. a Quantification of unc5b 
exon 8 inclusion (%) in zebrafish embryos (28 hpf) injected with a control morpholino (MO-ctr) or a morpholino 
against nova2 (MO-nova2). unc5b exon 8 AS was partially corrected by the co-injection of a morpholino-resistant 
nova2 mRNA (MO-nova2+nova2 mRNA). Error bars = ±SEM. One-Way ANOVA for multiple comparisons test (n=6). 
b Left: Schematic representation of the zebrafish unc5b genomic region encompassing exons 1, 2 and 3, and 
morpholino-resistant mCherry-tagged unc5b-FL/Δ8 mRNAs. Black boxes = constitutive exons; lines = introns. Unc5b 
splice-blocking morpholino (MO-unc5b) annealing to unc5b exon1-intron 1 junction is also shown. Red box = 
sequence encoding the C-terminal mCherry tag. Black arrows indicate primers used for RT-PCR. Right: analysis of 
splicing/retention of unc5b intron 1 in zebrafish embryos (72 hpf) injected with a control morpholino (MO-ctr) or a 
morpholino against unc5b (MO-unc5b), and expression of co-injected morpholino-resistant unc5b mRNA variants 
(unc5b-FL and unc5b-Δ8). β-actin mRNA as internal control. c Immunoblotting with an anti-mCherry antibody of 
HeLa cells transiently transfected with expression vectors expressing zebrafish Unc5b-FL and Unc5b-Δ8, or the empty 
vector. α-TUBULIN as loading control. At least three independent biological replicates were analyzed. d Fluorescence 
and brightfield images of Tg(kdrl:GFP) la116 unc5b-depleted zebrafish embryos (52 hpf) co-injected with different doses 
of unc5b-FL mRNA and quantification of PAV formation (right) (n=14,19,26,21,24). Arrow = PAV. Scale bar: 100 μm 
e Fluorescence and brightfield images of Tg(kdrl:GFP) la116 unc5b-depleted zebrafish embryos (52 hpf) co-injected with 
a lower dose (50 pg per embryo) of unc5b-Δ8 mRNA. Embryos injected with a control morpholino (MO-ctr) or (MO-
unc5b) are also shown. Right: quantification of PAV segments across ten ISV is shown. (n=6,12,21). Arrow = PAV. 
Scale bar: 100 μm f Left: lateral views (fluorescence) of Tg(kdrl:GFP) la116 zebrafish embryos (72 hpf) injected with a 
control morpholino (MO-ctr) or with a morpholino against unc5b (MO-unc5b); unc5b-morphants were also co-injected 
with two different doses of unc5b-FL mRNA (100 pg or 200 pg per embryo) or unc5b-Δ8 mRNA (100 pg per embryo). 
Asterisks indicate initiation of PAV sprouting. Arrow = PAV. Right: quantification of PAV in which sprouting 
initiation was observed upon co-injection of unc5b-FL and unc5b-Δ8 mRNA at different doses. One-way ANOVA for 
multiple comparisons. Error bars indicate ±SEM. Exact P-values (P) are indicated: * < 0.05; ** < 0.01; *** < 0.001; 




Supplementary Fig. 6. Unc5b-Δ8 overexpression characterization in a wild-type background. a Left: lateral views 
(fluorescence) of 6 dpf Tg(kdrl:GFP) la116 sibling wild-type like and nova2 CRISPR mutant. Right: quantification of 
PAV formation in 6 dpf wild-type (wt) and nova2 CRISPR mutants (mut). N. of larvae with normal PAV out the total n. 
of larvae. Scale bar: 100 µm. b Lateral views (fluorescence) of 5 dpf sibling wt-like, nova2 mutant, and nova2 mutant 
injected with unc5b mRNA variants (unc5b-FL and unc5b-Δ8). Dorsal aorta (DA; white) and posterior cardinal vein 
(PCV, red) diameters are highlighted. Scale bar: 25 μm. c Morphological analysis of 24 hpf Tg(fli1a:GFP)y1 embryos 
injected with different doses of unc5b-Δ8 mRNA. The percentage of embryos with an altered phenotype is reported in 
the graph on the right. Scale bar: 100 μm d Evaluation of intersegmental vessel (ISV) defects in the above embryos. 
Arrow indicates a correctly formed ISV. Asterisks indicate defective ISVs. Scale bar: 100 μm e and f Morphological 
and ISV formation analyses of Tg(fli1a:GFP)y1 embryos injected with different doses of unc5b-Δ8 mRNA are also 






Supplementary Fig. 7. Localization and Netrin-1 binding of UNC5B isoforms. a Membrane localization of 
UNC5B-FL and UNC5B-Δ8 in inducible moEC. Scale bar is indicated. b Analysis by RT-qPCR (relative to ACTB) and 
immunoblotting of UNC5B expression levels in HeLa and, as positive control, in SH-SY-5Y cells. α-TUBULIN as 
loading control. Two-tailed Student’s t-test. Error bars indicate ±SEM. Exact P-value (P) is indicated: **** < 0.0001; c 
Membrane localization of GFP-tagged and HA-tagged UNC5B isoforms in transiently transfected HeLa cells. Scale 
bars are indicated. At least three independent biological replicates were analyzed. d Left: pull-down of surface 
biotinylated membrane proteins in HeLa cells transiently transfected with HA-tagged UNC5B isoforms, the L1-CAM 
transmembrane receptor (L1) as positive control, or with the empty vector (vector). GAPDH as internal control. Right: 
quantification of UNC5B isoforms relative surface expression (IP/INPUT ratio). n=4. Two-tailed Paired Student's t-test. 
Exact P-value (P) is indicated: ns = not significant. e Representative surface plasma resonance (SPR) analyses of 
recombinant UNC5B-FL (left) and UNC5B-Δ8 ectodomains (center) binding with Netrin-1 on a BIAcore T200. Red 
bars indicate the equilibrium dissociation constant (KD). KD was calculated for three independent experiments for each 
ectodomain (right). f Immunoblotting (anti-GFP) of UNC5B AS isoforms in transiently transfected HeLa cells with 
plasmids encoding either UNC5B-FL-GFP, UNC5B-Δ8-GFP, or GFP. α-TUBULIN as loading control. At least three 





Supplementary Fig. 8. UNC5B-Δ8 prevents Netrin-1 pro-survival signaling in ECs. a Left: analysis by RT-qPCR 
(relative to GAPDH) of UNC5B-AS isoforms (FL and Δ8) transduced in HUVEC. Right: Caspase-3 activation in 
HUVEC transduced with adenoviral vectors expressing UNC5B-FL-GFP, UNC5B-Δ8-GFP, or GFP treated with or 
without Netrin-1 (150 ng/ml). n=3. b Immunoblotting (anti-GFP) of UNC5B AS isoforms in moEC transduced with 
inducible UNC5B-FL-GFP, UNC5B-Δ8-GFP or GFP induced with doxycycline for 12 h. α-TUBULIN as loading 
control. Two-tailed Paired Student’s t-test. n=12; error bars indicate ±SEM. Exact P-value (P) is indicated: * < 0.05; ns: 
not significant. c Vital exclusion assay (left) and immunoblotting against the cleaved (activated form) of Caspase-3 
(right) in the above moEC induced with doxycycline for 6 hr (n = 4,6,8,8,8,8) or (d) 12 hr in the presence of Netrin-1 
(150 ng/ml) (n=4); α-TUBULIN as loading control. One-way ANOVA for multiple comparison; error bars indicate 
±SD. Scale bar: 100 μm. e Cell death evaluation, by TUNEL assay, on 48 hpf Tg(fli1a:GFP)y1 wild-type zebrafish 
embryos injected with 100 pg (per embryo) of unc5b-Δ8 mRNA. Dying ECs are indicated by arrows. f TUNEL assay in 
52 hpf Tg(kdrl:GFP) la116 injected with a control morpholino (MO-ctr) or with a morpholino against unc5b (MO-
unc5b); unc5b-morphants were also co-injected with 50 pg of a morpholino-resistant zebrafish unc5b-Δ8 and treated 
with two different caspase inhibitors (Q-VD-Oph and Z-VAD-FMK). Arrows indicate TUNEL-positive ECs. For each 
condition the number of embryos with co-localization of GFP and TUNEL signals is provided. Scale bar: 100 μm. g 
Lateral views (fluorescence) of the above zebrafish embryos. Arrows: forming PAV. The analyzed region of zebrafish 
trunk is highlighted in the red box in the brightfield Right: Quantification of PAV formation in the above zebrafish 
embryos. n= 6,17,9,12,12. Scale bar: 100 μm. One-way ANOVA for multiple comparison; error bars indicate ±SEM. 




Supplementary Fig. 9. EC apoptosis during zebrafish development. a Terminal deoxynucleotidyl transferase (TdT) 
dUTP Nick-End Labeling (TUNEL) assay in Tg(kdrl:GFP) la116 zebrafish embryos at 30 hpf, 33 hpf, and 48 hpf 
developmental stages. The trunk and tail regions of four different embryos (#1-4) are shown. Arrows indicate TUNEL-
positive ECs. Arrowheads indicate dying cells in close proximity to PAV sprouting region in the ISV. b Presence of 
TUNEL-positive ECs was also confirmed in Tg(fli1a:GFP)y1 embryos at 30 hpf; 33 hpf, and 52 hpf. Arrows indicate 
TUNEL-positive ECs. The number of embryos with co-localization of GFP and TUNEL signals is provided. Scale bar: 
100 μm. c Apoptotic cell-death in the above Tg(fli1a:GFP)y1 zebrafish embryos was confirmed by immunostaining for 
cleaved Caspase-3 (CC3) immunostaining. Co-localization of EC-restricted GFP and CC3 signals are indicated by 





Supplementary Fig. 10. Morpholino-mediated inhibition of UNC5B-Δ8 production reduces tube formation 
capabilities of human ECs. a Schematic representation of the human UNC5B pre-mRNA with the NOVA2 binding 
sites (YCAY cluster predicted by RBPmap tool and indicated in different colors according to their calculated Z-score) 
and the complementary annealing region of the morpholino oligo (UNC5B-i7) in intron 7. b RT-PCR analysis of 
UNC5B exon 8 splicing in HUVEC/TERT2 treated with UNC5B-i7 or a control morpholino oligo (Ctr). The percentage 
of exon 8 inclusion is shown below the gel. c RT-qPCR (relative to ACTB) of total UNC5B expression levels in the 
same HUVEC/TERT2 cells. Two-tailed Student’s t-test; error bars indicate ±SEM. Exact P-value (P) is indicated: ns = 
not significant. n=3. d Left: in vitro angiogenesis assay of HUVEC/TERT2 treated with UNC5B-i7 morpholino or a 
MO-Ctr morpholino oligos and plated on Matrigel-coated culture plates. Scale bar: 0.5 mm. Right: quantification of the 
number (#) of nodes and segments. One experiment of three different biological replicate is shown (n=5,4). Two-tailed 








Supplementary Fig. 11. NOVA2 is upregulated in ECs of human colon cancer vasculature. a IHC images for 
double staining of NOVA2 and the vessel marker CD31 in 10 cases of colorectal cancer patients. For each case tumor 
and normal adjacent tissue are shown. Scale bars: 200 µm. b Representative IHC images for double staining of NOVA2 
and CD31 in KRAS mutated (I) or wild type (II) colon cancer samples (n = 4). NOVA2 is selectively expressed by 
tumor ECs co-expressing CD31. Scale bars: 60 µm, magnification 400X. c Quantification of NOVA2 positive cells 
(left) and NOVA2 positive cells with strong IHC signal (right) relative to total cell area and total NOVA2 positive cells, 
respectively, in tumor specimens (TUMOR) and normal adjacent tissue (NAT). Two-tailed Student’s t-test with 
Welch's correction. Error bars indicate ±SEM. Exact P-values (P) are indicated: * P-value < 0.05; ** P-value < 0.01. 
 
 
Supplementary Fig. 12. NOVA2 is upregulated in ECs of different human carcinomas. a Representative IHC 
images for NOVA2 staining in two cases of oral cavity carcinoma (I and III) and in two cases of hepatocarcinoma (II 
and IV). NOVA2 shows upregulation in tumor ECs. Normal adjacent tissue (N) and tumor (T) areas are shown. Scale 
bars: 200 µm. n=5. b Quantification of NOVA2 positive cells relative to total cells are in tumor specimens (TUMOR) 
and normal adjacent tissue (NAT). Two-tailed paired Student’s t-test. Error bars indicate ±SEM. Exact P-values (P) are 
indicated:  ** < 0.01. c RNA-seq data analysis of NOVA2 mRNA expression levels, PSI (Percent Spliced-In) of UNC5B 
exon 8, and correlation between NOVA2 and UNC5B-Δ8 expression in normal (blue) and primary tumor (red) samples 
in the TCGA-LIHC (Liver Hepatocellular Carcinoma) and (d) TCGA-HNSC (Head-Neck Squamous Cell Carcinoma) 
datasets, respectively. Left: Box plot represents upper quartile, median, lower quartile. Error bars indicate minimum and 
maximum. Two-tailed Log-ranked test. Exact P-values (P) are indicated: **** < 0.0001. Centre: Two-tailed paired 
Student’s t-test. Error bars indicate ±SEM. Exact P-values (P) are indicated: * P-value < 0.01; **** < 0.0001. Right: 











Supplementary Fig. 13. UNC5B-Δ8 chromogenic BaseScope probe validation and UNC5B-Δ8 selectively 
expression by colon cancer ECs. a Schematic representation of the ISH assay with a chromogenic BaseScope probe 
(Z) specific for UNC5B-Δ8 mRNA. Signal amplification occurs only in UNC5B transcripts deleted of exon 8 in which a 
single pair of BaseScopes probes (ZZ) is constituted. Visualization of the UNC5B-Δ8 mRNA expression is indicated as 
red dots. b Right: RT-PCR analysis of NIH/3T3 mouse fibroblasts transfected with human UNC5B-FL, UNC5B-Δ8 
cDNA, or the empty vectors. Gapdh as internal control. Left: the same cells were also analyzed by ISH with the 
UNC5B-Δ8 probe. No signal was observed in NIH/3T3 cells expressing UNC5B-FL. c Representative images of ISH in 
the colon cancer samples with KRAS mutated (I-IV) or wild type (VII-IX) by using the positive CTR or the UNC5B-Δ8 
BaseScope probes. Whereas the signal from the CTR probe is widespread in different tumor cell types (I, IV, VII), 
UNC5B-Δ8 expression is restricted to ECs (II, V, VIII), as highlighted in the corresponding high-power view (III, VI, 
IX). n=4. I, II, IV, V, VII, VIII scale bars: 60 µm, magnification: 400X; III, VI, IX scale bars 30 µm, magnification 
800X.  
 
Supplementary Fig. 14. NOVA2/UNC5B-Δ8 axis in colon cancer patients. a NOVA2 mRNA expression levels 
(microarray analysis) from Oncomine (http://oncomine.org/resource) in TCGA Colorectal and (b) Kaiser datasets. Box 
plot represents upper quartile, median, lower quartile. Error bars indicate minimum and maximum. c UNC5B splicing 
analysis by RT-PCR in normal colon tissues [N], colon primary tumors [T] and liver metastasis [M]. Quantification of 
PSI (Percent Spliced-In) of UNC5B exon 8 on the right. d NOVA2 mRNA levels by RT-qPCR (relative to ACTB) in the 
above normal, primary tumor, and metastasis specimens. RM one-way ANOVA; Error bars ±SEM. e Correlation 
between NOVA2 expression and UNC5B splicing (PSI) in normal colon tissue (blue circle), colon primary tumor (red 
circle) and liver metastasis (violet circle). Linear regression (black line) and Pearson r coefficient with two-tailed P 
value are also calculated. f Kaplan-Meier plot of metastasis-free (GSE28722) and (g) relapse-free survival in colon 
adenocarcinoma patients classified according to NOVA2 expression (GSE31595 and GSE28814). Blue curve: low 
expression (< 75th percentile); red curve: high expression (>75th percentile); data from PROGgeneV2 tool 
(http://genomics.jefferson.edu/proggene). Two-tailed Student’s t-test. Exact P-values (P) are indicated: * < 0.05; ** < 












Supplementary Fig. 15. Apoptosis in NOVA2-positive human colon cancer ECs. a Representative IHC images for 
triple staining of NOVA2, the endothelial marker CD31, and cleaved Caspase-3 (CC3) in human colorectal cancer 
specimens. Black arrowheads indicate apoptotic (cleaved Caspase-3 positive) tumor ECs (CD31 positive) that shown 
also NOVA2 nuclear signal. n=8. Scale bar: 30 µm. b Representative IHC images for triple staining of NOVA2, the 
endothelial marker CD31, and cleaved Caspase-3 (CC3) in tumor (I and III) and normal adjacent tissue (II and IV) 




Supplementary Fig. 16. Identification of UNC5B intrinsically disordered region (IDR). a GlobPlot prediction 
analysis (http://globplot.embl.de) of human (Q8IZJ1), mouse (Q8K1S3), and zebrafish (A9JR35) UNC5B proteins. 
Low-complexity (yellow), disordered (blue), and globular (green) regions are shown on the x-axis, where UNC5B 
residues are indicated. Violet box indicates the position of the 11 residues encoded by exon 8. Predicted UNC5B 
domains and their relative position are shown in different colors: IG-like domain (aqua green), Igc2 domain (dark 
green), TSP1 (light green); TSP1 (yellow), transmembrane domain (pale orange); ZU5 domain (orange); death domain 
(red). Russell-Linding cumulative propensity of disorder is also shown (white line). b Graphic representation of 
PONDR prediction output (http://www.pondr.com), obtained by using the VLS2 algorithm optimized for long and short 
disordered regions, of human, mouse, and zebrafish UNC5B-FL (upper panels) and UNC5B-Δ8 (lower panels) protein 
isoforms. PONDR score for each residue is shown. Red boxes indicate the position of the 11 residues encoded by exon 
8 in UNC5B-FL. Black arrows indicate the absence of a disorder peak (PONDR score > 0.5) in UNC5B-Δ8 region 




Supplementary Fig. 17. Identification of NEOGENIN intrinsically disordered region (IDR). a GlobPlot prediction 
analysis (http://globplot.embl.de) of human (Q92859) and mouse (P97798) NEOGENIN proteins. Low-complexity 
(yellow), disordered (blue), and globular (green) regions are shown on the x-axis, where NEOGENIN residues are 
indicated. Violet box indicates the position of the 53 residues encoded by exon 27. Predicted NEOGNIN domains and 
their relative position are shown in different colors:  Igc2 domain (light blue, azure, aqua green, and green), FN3 (light 
green, yellow, pale orange, orange, and red), transmembrane domain (white). Russell-Linding cumulative propensity of 
disorder is also shown (white line).  
 
 
Supplementary Fig. 18. Validation of TUNEL analysis in zebrafish embryo, representative images for 
NOVA2+ ECs quantification in human tumor specimens, and validation of cleaved Caspase-3 IHC analysis. a 
Representative images of 24 hpf Tg(kdrl:GFP) la116 zebrafish embryos treated with DNAse and stained with TUNEL 
(terminal deoxynucleotidyl transferase dUTP nick end labeling). GFP signal, TUNEL signal, and composite image are 
shown. Scale bar: 100 μm. b On the left column native images are from two representative human CRC 
specimens stained for NOVA2 and counterstained with hematoxylin. On the right column, the corresponding processed 
areas are shown. Strongly positive cells (red) and weakly positive cells (yellow) are illustrated in the right 
column. Images acquired from digital slides using 200X magnification have been digitally resized using Adobe 
Photoshop. Scale bar: 200 µm. c Burkitt's lymphoma as Cleaved Caspase-3 (CC3) staining positive control. Reactive 
lymph nodes as a negative control. Scale bar: 200 µm. d Isotype and omission controls of Cleaved Caspase-3 (CC3) 
antibody in two cases (Case #1 and #2) of human CRC counterstained with hematoxylin. Scale bar: 200 µm. 















































Supplementary Table 1. Primers used in RT-PCR, RT-qPCR, and cloning experiments. 
 
Primer name Sequence (5'à3') 
 RT-PCR experiments:  
 mouse-Unc5b_E8-F  CCAAGAACTGCACTGATGGG 
 mouse-Unc5b_E8-R  GAAGTTGACAGGGTGGAAGC 
 human-UNC5B_E8-F  GACGGAGTGGAGCAAGTGGT 
 human-UNC5B_E8-R  ACGAAGATGGCCACCACGAG 
 human-UNC5B_E8-F_shift  GCGTAGCCGCGAGTGCAT 
 human-UNC5B_E8-R_shift  GCATCCCCTGAGGCCTC 
 zebrafish-unc5b_E8-F  TCGTGAATGTCAGGCTCCAC  
 zebrafish-unc5b_E8-R  CGGCGATAGACCAGAATCCC  
 zebrafish-unc5b_i1-F  GGAGTCGCACTGTCTGGATT 
 zebrafish-unc5b_i1-R  CCGCCCACTGTTCTATGAGC 
 mCherry-F  CAGCTCTGGAAGAGATGGGC 
 mCherry-R  CTCCATGTGCACCTTGAAGC 
 zebrafish-actb-F  ACATCAGGGTGTCATGGTTGGT 
 zebrafish-actb-R  CGCAGCTCGTTGTAGAAGGTGT 
 BGH-rev  TAGAAGGCACAGTCGAGG 
 RT-qPCR experiments:  
 mouse-Nova2-F  AGGACTGATCATCGGTAAGG 
 mouse-Nova2-R  GGGTCTTCCTGTACCTTCTG  
 human-NOVA2-F  CAGCTTTATTGCCGAGAAGG  
 human-NOVA2-R  ACCCATGCTCCTGACTGTTC 
 zebrafish-nova2-F  CATTATTGGCAAGGGTGGTC 
 zebrafish-nova2-R  TGCAATGAAGTCGTGGACAT 
 human-COL4A1-F  CTACGTGCAAGGCAATGAACG 
 human-COL4A1-R  GCAGAACAGGAAGGGCATTGT 
 mouse/human-Gapdh-F   TCAAGAAGGTGGTGAAGCAGG 
 mouse/human-Gapdh-R  ACCAGGAAATGAGCTTGACAAA 
 mouse-Ubb-F   TCTTCGTGAAGACCCTGACC  
 mouse-Ubb-R  CAGGTGCAGGGTTGACTCTT  
 human-ACTB-F  AGAGCTACGAGCTGCCTGAC 
 human-ACTB-R  AGTTTCGTGGATGCCACAGG 
 human-B2M-F  AAGTGGAGCATTCAGACTTGT 
 human-B2M-R  CACGGCAGGCATACTCATCT 
 CLIP-Unc5b_A-F  AGCTGTAGGGCCTCTGTCTG 
 CLIP-Unc5b_A-R  GTGACAGAGAAAGGGTGGCC 
 CLIP-Unc5b_B-F  CTCCTTGGCTGGCTTTCCAT 
 CLIP-Unc5b_B-R  GCATGCATGAGGTACAGGGA 
 CLIP-Unc5b_C-F  GTGAGTGTGGAGCTGAGCTT 
 CLIP-Unc5b_C-R  AAGCCAGGAGGTGCTAGAGA 
 human-Unc5b-F   CTGGGACCTTATGCCTTCAA 
 human-Unc5b-R  CGCTTTGGTGGCAAAGTAAT  
 Cloning experiments:  
 Unc5b-For-HindIII CC  CAAGCTTACCATGAGGGCCCGGAGCGGGGTGC 
 Unc5b-Rev-EcoRI-HA 
 
 CCGGAATTCTCAAGCGTAATCTGGAACATCGTATG             
 GGTACATTCCGCAATCGCCATCTGTGGCCATG 
 Unc5b-Rev-EcoRI-GFP  CCGGAATTCGTCCGCAATCGCCATCTGTGGCCATG 
 Unc5b-deletion_E8-F  TGATGGGCTGTGCGTGCTGACCCTGGAGACATCGG  GAGAT 
 Unc5b-deletion_E8-R  ATCTCCCGATGTCTCCAGGGTCAGCACGCACAGCCC  ATCA 
 Unc5b_minigene_F  CCCGGATCCTGGATGGAGCGTGGACCGA 
 Unc5b_minigene_R  GGGGAATTCTGGGCCTTGCAGTCTTGAAG 





 Unc5b_zebrafish-F  GCCGGATCCGGTACCACGCGTGACCGGGTGAAGA  TGCT 
 Unc5b_zebrafish-R  TTGGGATCCTCCAGTAAAACC 
 Unc5bEcto-deletion_E8-F  TGCTGGAGGCCTCAGGGGAT 
 Unc5bEcto-deletion_E8-R  TTTGCATGCACAGCCCATCT 
 In vitro RNA pull down:  
 T7_YCAYcluster_F  TAATACGACTCACTATAGGGCCTCTGTCTGGCCC 
 TDP43_YCAYcluster _R  CACACACACACACACACTAAAGGGAAAGATG 
 
Supplementary Table 2. Morpholino antisense oligonucleotide. 
 
Morpholino name Sequence (5'à3') 
 zebrafish-MO-unc5b  CATTTAACCGGCTCGTACCTGCATG 
 human-MO-i7_UNC5B  AAGGATGAGATGAGATGATGGATGT 
 
 
